Among the DM-IP patients in this study, the anti-MDA5 Ab-positive rate, the serum ferritin level at the initiation of treatment, the AaDO2 level, and the GGO score on chest HRCT were significantly higher in the fatal IP group than in the survivor group, which was consistent with previous reports. The gene discussed is IFIH1; the disease is incontinentia pigmenti.